Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $270.74 million. The enterprise value is $207.71 million.
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 52.37 million shares outstanding. The number of shares has increased by 3.71% in one year.
| Current Share Class | 52.37M |
| Shares Outstanding | 52.37M |
| Shares Change (YoY) | +3.71% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 20.77% |
| Owned by Institutions (%) | 25.72% |
| Float | 28.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.53 |
| Forward PS | 3.38 |
| PB Ratio | 3.92 |
| P/TBV Ratio | 3.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.01, with a Debt / Equity ratio of 0.58.
| Current Ratio | 10.01 |
| Quick Ratio | 9.31 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.02 |
Financial Efficiency
Return on equity (ROE) is -57.10% and return on invested capital (ROIC) is -24.61%.
| Return on Equity (ROE) | -57.10% |
| Return on Assets (ROA) | -22.40% |
| Return on Invested Capital (ROIC) | -24.61% |
| Return on Capital Employed (ROCE) | -44.24% |
| Revenue Per Employee | $353,255 |
| Profits Per Employee | -$226,884 |
| Employee Count | 216 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.72 |
Taxes
In the past 12 months, Sight Sciences has paid $285,000 in taxes.
| Income Tax | 285,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.58% in the last 52 weeks. The beta is 2.41, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.41 |
| 52-Week Price Change | -0.58% |
| 50-Day Moving Average | 3.85 |
| 200-Day Moving Average | 3.36 |
| Relative Strength Index (RSI) | 74.95 |
| Average Volume (20 Days) | 225,469 |
Short Selling Information
The latest short interest is 996,196, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 996,196 |
| Short Previous Month | 1.04M |
| Short % of Shares Out | 1.90% |
| Short % of Float | 3.45% |
| Short Ratio (days to cover) | 10.16 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $76.30 million and -$49.01 million in losses. Loss per share was -$0.96.
| Revenue | 76.30M |
| Gross Profit | 65.15M |
| Operating Income | -48.68M |
| Pretax Income | -48.72M |
| Net Income | -49.01M |
| EBITDA | -48.08M |
| EBIT | -48.68M |
| Loss Per Share | -$0.96 |
Full Income StatementBalance Sheet
The company has $101.50 million in cash and $40.57 million in debt, giving a net cash position of $60.93 million or $1.16 per share.
| Cash & Cash Equivalents | 101.50M |
| Total Debt | 40.57M |
| Net Cash | 60.93M |
| Net Cash Per Share | $1.16 |
| Equity (Book Value) | 70.01M |
| Book Value Per Share | 1.35 |
| Working Capital | 107.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.25 million and capital expenditures -$398,000, giving a free cash flow of -$22.64 million.
| Operating Cash Flow | -22.25M |
| Capital Expenditures | -398,000 |
| Free Cash Flow | -22.64M |
| FCF Per Share | -$0.43 |
Full Cash Flow StatementMargins
Gross margin is 85.38%, with operating and profit margins of -63.80% and -64.23%.
| Gross Margin | 85.38% |
| Operating Margin | -63.80% |
| Pretax Margin | -63.85% |
| Profit Margin | -64.23% |
| EBITDA Margin | -63.01% |
| EBIT Margin | -63.80% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.71% |
| Shareholder Yield | -3.71% |
| Earnings Yield | -18.24% |
| FCF Yield | -8.43% |
Analyst Forecast
The average price target for Sight Sciences is $4.50, which is -12.96% lower than the current price. The consensus rating is "Buy".
| Price Target | $4.50 |
| Price Target Difference | -12.96% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 9.56% |
| EPS Growth Forecast (5Y) | -7.11% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of -1.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.34 |
| Piotroski F-Score | 2 |
